During the past decade, eMax Health conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "eMax Health" are "Asthma" (2 trials) and "Pulmonary Disease, Chronic Obstructive" (1 trials). Many other conditions were trialed in "eMax Health" in a lesser frequency.

Most popular intervention types in "eMax Health" are "Drug" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Fluticasone Furoate + Umeclidinium + Vilanterol (100/62.5/25 mcg)" (1 trials), "Inhaled Corticosteroid/Long-acting beta-agonist" (1 trials), "Stiolto Respimat" (1 trials), "Tiotropium + Olodaterol (5/5 mcg)" (1 trials) and "Tiotropium Respimat®" (1 trials). Other intervention names were less common.

The vast majority of trials in "eMax Health" are 3 trials for "All" genders.

Currently, there are NaN active trials in "eMax Health". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in eMax Health, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in eMax Health, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".